Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10254 |
| Vaccine Name | GX-19 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | DNA based vaccine |
| Vaccine Status | Phase 2 |
| Manufacturer | Genexine Consortium |
| Year of Manufacturing | 2021 |
| Manufacturing Country | South Korea |
| Age | 18 - 55 years |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | SARS-CoV-2 S-protein antigen including the Nucleocapsid protein antigen |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 33816047 |
| Clinical Trial ID | NCT04715997 |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ |
| Additional Links | NA |